Carlos M. De Castro, MD, provides updates regarding treatment for paroxysmal nocturnal hemoglobinuria (PNH) from the ASH 2022 Annual Meeting and Exposition.
EP. 1: Phase III Apply-PNH Study Overview
Carlos M. De Castro, MD, highlights the phase III Apply-PNH study presented at ASH 2022.
EP. 2: Selecting Optimal Treatment Therapies for PNH
Dr De Castro provides an overview of IV versus oral therapies for patients with PNH.
EP. 3: Biosimilar Integration into PNH Treatment Landscape
Biosimilar products may be utilized as treatment options in PNH.
EP. 4: Cost Utilization Analysis in PNH Treatment Pathways
Dr De Castro explores considerations surrounding cost in treatment of PNH.
EP. 5: Unmet Needs Surrounding PNH
In his closing thoughts, Dr De Castro provides a final overview of the ASH conference, highlighting updates in PNH treatment.
2 Clarke Drive Cranbury, NJ 08512